Bromide

Bromide

SCHEMBL27619464

Br.NC(C(=O)Nc1nc(-c2ccncc2)cs1)c1ccccc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ROCK1 Q13464 18/20 0.67
▸ ROCK2 O75116 15/20 0.67
▸ PARP1 P09874 1/20 0.60
▸ PRKACA P17612 1/20 0.58
▸ KDM4E B2RXH2 1/20 0.56
▸ LMNA P02545 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ MAPK1 P28482 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3252039 0.99 ROCK1 (0.68) ROCK1ROCK2PARP1PRKACAKDM4E
SCHEMBL13357658 0.99 ROCK1 (0.68) ROCK1ROCK2PARP1PRKACAKDM4E
SCHEMBL13357606 0.85 ROCK1 (0.70) ROCK1ROCK2PARP1PRKACAKDM4E
SCHEMBL3257615 0.84 ROCK1 (0.68) ROCK1ROCK2PARP1PRKACAKDM4E
SCHEMBL13357663 0.83 ROCK1 (0.59) ROCK1ROCK2
SCHEMBL13357625 0.82 ROCK1 (0.66) ROCK1ROCK2PARP1PRKACA
SCHEMBL2752587 0.82 ROCK1 (0.69) ROCK1ROCK2PARP1PRKACALMNA
SCHEMBL10253197 0.81 ROCK1 (0.71) ROCK1ROCK2PRKACALMNASMN1; SMN2
SCHEMBL2554763 0.80 ROCK1 (1.00) ROCK1ROCK2PARP1
SCHEMBL2559941 0.79 ROCK1 (1.00) ROCK1ROCK2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1732164-A Compositions useful as inhibitors of ROCK and other protein kinases VERTEX PHARMA (US) 2006-02-08 — — CN disclosed
Send feedback